Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Alnylam Pharmaceuticals (ALNY)’

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

5 Mid-Cap Stocks That Insiders Love

Recent research conducted at InsiderMonkey has shown that stocks bought by insiders tend to outperform market indexes. Although insider purchases alone......(read more)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Three Stocks That Have Wittnessed Millionaire Insider Purchases Lately

Tracking insider purchases can provide an investor with great ideas, just like keeping an eye on hedge fund moves. This is why, in this article, I will......(read more)
Steven Cohen

Infinity Pharmaceuticals Inc. (INFI): Billionaire Steve Cohen’ SAC Up to 5% of This Stock

According to a 13G filed with the SEC, SAC Capital Advisors, a hedge fund managed by billionaire Steve Cohen, owned 2.4 million shares of Infinity Pharmaceuticals......(read more)
Ken Griffin CITADEL INVESTMENT GROUP

A Synageva Board Member’s Trusts Bought Shares

Trusts related to Board of Directors member Thomas Tisch purchased about 21,000 shares of Synageva Biopharma Corp (NASDAQ:GEVA) on January 9th at an average......(read more)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

7 Biotech Stocks Trading At Steep Discount To Target Price

A quick way to discover potentially undervalued stocks is to look for ones with a current price below the current mean analyst target price. Last year......(read more)